Ennishi et al. [37] utilized targeted resequencing, whole-exome sequencing, RNA sequencing, and immunohistochemistry to develop a gene-expression signature (DHITsig) that was able to distinguish HGBL-DH/TH-BCL2 from GCB-DLBCL. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.